Gene · 1237
Papers2,300
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,300
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Prognostic and immunological potential of PPM1G in lung adenocarcinoma. | Mol Med Rep | 2023 | 37387407 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing highlights the role of PVR/PVRL2 in the immunosuppressive tumour microenvironment in hepatocellular carcinoma. | Front Immunol | 2023 | 37383234 | PubTator, text mining | PubMed |
| CD25high Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer. | Cancer Res | 2023 | 37379438 | PubTator, text mining | PubMed |
| Mechanistic rationales for combining immunotherapy with radiotherapy. | Front Immunol | 2023 | 37377970 | PubTator, text mining | PubMed |
| Cigarette Smoke-Induced Respiratory Response: Insights into Cellular Processes and Biomarkers. | Antioxidants (Basel) | 2023 | 37371940 | PubTator, text mining | PubMed |
| Expression of CCR8 and CCX-CKR on Basophils in Chronic Urticaria Is Amplified by IgE-Mediated Activation. | Biomedicines | 2023 | 37371632 | PubTator, text mining | PubMed |
| Promoter hypermethylation and comprehensive regulation of ncRNA lead to the down-regulation of ZNF880, providing a new insight for the therapeutics and research of colorectal cancer. | BMC Med Genomics | 2023 | 37370088 | PubTator, text mining | PubMed |
| Immunotherapy Targeting CCR8+ Regulatory T Cells Induces Antitumor Effects via Dramatic Changes to the Intratumor CD8+ T Cell Profile. | J Immunol | 2023 | 37350632 | PubTator, text mining | PubMed |
| The biological function of tumor-derived extracellular vesicles on metabolism. | Cell Commun Signal | 2023 | 37349803 | PubTator, text mining | PubMed |
| The role of transcription factors in shaping regulatory T cell identity. | Nat Rev Immunol | 2023 | 37336954 | PubTator, text mining | PubMed |
| Multi-dimensional single-cell characterization revealed suppressive immune microenvironment in AFP-positive hepatocellular carcinoma. | Cell Discov | 2023 | 37336873 | PubTator, text mining | PubMed |
| Leucyl and Cystinyl Aminopeptidase as a Prognostic-Related Biomarker in OV Correlating with Immune Infiltrates. | Pharmgenomics Pers Med | 2023 | 37293607 | PubTator, text mining | PubMed |
| Integrated high-throughput analysis identifies super enhancers in metastatic castration-resistant prostate cancer. | Front Pharmacol | 2023 | 37292153 | PubTator, text mining | PubMed |
| [Activity of the telomerase complex before and after CPAP therapy in patients with obstructive sleep apnea syndrome]. | Zh Nevrol Psikhiatr Im S S Korsakova | 2023 | 37276007 | PubTator, text mining | PubMed |
| The role of tumor-infiltrating lymphocytes in triple-negative breast cancer and the research progress of adoptive cell therapy. | Front Immunol | 2023 | 37275874 | PubTator, text mining | PubMed |
| A ceRNA network-mediated over-expression of cuproptosis-related gene SLC31A1 correlates with poor prognosis and positive immune infiltration in breast cancer. | Front Med (Lausanne) | 2023 | 37275369 | PubTator, text mining | PubMed |
| SPARTIN: a Bayesian method for the quantification and characterization of cell type interactions in spatial pathology data. | Front Genet | 2023 | 37274781 | PubTator, text mining | PubMed |
| Modulation of T cell function and survival by the tumor microenvironment. | Front Cell Dev Biol | 2023 | 37274739 | PubTator, text mining | PubMed |
| Analysis and validation of the potential of the MYO1E gene in pancreatic adenocarcinoma based on a bioinformatics approach. | Oncol Lett | 2023 | 37274465 | PubTator, text mining | PubMed |
| Cellular activation pathways and interaction networks in vascularized composite allotransplantation. | Front Immunol | 2023 | 37266446 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1237/papers?page=14